Vuralia turcica (Fabaceae; Papilionoideae) is a critically endangered endemic plant species in Turkey. This plant grows naturally in saline environments, though the photosynthesis and physiological capabilities of many crops are affected by salt stress. Molecular management mechanisms and identification of genes concerned in these mechanisms represent the important area of examine in plant science. Trehalose-6-phosphate synthase (TPS) is one of the important enzyme genes concerned in trehalose biosynthesis, which is protecting in opposition to salt stress.
Also, the vacuolar Na+/H+ antiporter gene (NHX) is understood to be helpful in salt tolerance. In this examine, the TPS and NHX-like genes in V. turcica had been partially sequenced utilizing degenerate primers for the primary time and submitted to the NCBI database (accession numbers MK120983 and MH757417, respectively). Also, the expression ranges of the genes encoding TPS and NHX had been investigated.
The outcomes point out that the rise in each the extent of utilized salt and cadmium is coupled with the rise in the expression degree of NHX and TPS genes. However, salt publicity considerably affected the expression degree of the NHX gene. The findings recommend that the NHX gene may play an important position in the salt tolerance capacity of V. turcica.
Acute exposition to Roundup Transorb® induces systemic oxidative stress and alterations in the expression of newly sequenced genes in silverside fish
Roundup Transorb® (RDT) is a glyphosate-based herbicide generally used in agricultural practices worldwide. This herbicide exerts adverse results on the aquatic ecosystem and impacts bioenergetic and detoxing pathways, oxidative stress, and cell injury in marine organisms. These results may also happen on the transcriptional degree; nonetheless, the expression of genes related to oxidative stress has not been studied effectively. Odontesthes humensis is a local Brazilian aquatic species naturally distributed in the habitats affected by pesticides, together with Roundup Transorb® (RDT).
This examine evaluated the poisonous results of short-term publicity to RDT on O. humensis. Moreover, the genes associated to oxidative stress had been sequenced and characterised, and their expressions in the gills, hepatopancreas, kidneys, and mind of the fish had been quantified by quantitative reverse transcription-polymerase chain response. The animals had been uncovered to 2 environmentally related concentrations of RDT (2.07 and 3.68 mg L-1) for 24 h. Lipid peroxidation, reactive oxygen species (ROS), DNA injury, and apoptosis in erythrocytes had been quantified by circulation cytometry.
The expression of the goal genes was modulated in most tissues in the presence of the best examined focus of RDT. In erythrocytes, the degrees of lipid peroxidation, ROS, and DNA injury had been elevated in the presence of each the concentrations of RDT, whereas cell apoptosis was elevated in the group uncovered to three.68 mg L-1 RDT. In conclusion, acute publicity to RDT brought about oxidative stress in the fish, induced adverse results on cells, and modulated the expression of genes associated to the enzymatic antioxidant system in O. humensis.
Silver nanoparticles’ impression on the gene expression of the cytosolic adaptor MyD-88 and the interferon regulatory issue IRF in the gills and digestive gland of mytilus galloprovincialis
Silver nanoparticles (AgNPs) have been reported as stressors for the bivalves’ immune system at completely different regulatory ranges, impacting the detection step and receptors, and different mediators, in addition to effector molecules. However, research on how AgNPs impression the transmission of indicators from receptors and whether or not they impact mediators and transcription elements are nonetheless scarce.
This examine goals to research the impact of 12 hours of in vivo publicity to 100 µg/L of AgNPs on the gene expression of the cytosolic adaptor Myeloid, the differentiation protein 88 (MgMyD88-b), and the interferon regulatory issue (Me4-IRF) in the gills and digestive gland of Mytilus galloprovincialis, earlier than and after blocking two main uptake pathways of nanoparticles (clathrin- and caveolae-mediated endocytosis).
The outcomes illustrate a tissue-specific gene expression of the MgMyD88-b and the Me4-IRF in the gills and digestive gland of M. galloprovincialis. In the gills, AgNPs didn’t considerably impression the expression of the 2 genes. However, blocking the caveolae-mediated endocytosis decreased the expression of Me4-IRF. However, inhibition of clathrin-mediated endocytosis in the digestive gland recorded a major lower in the expression of MgMyD88-b. Overall, the inhibition of the AgNPs’ uptake routes have highlighted their potential interference with the immune response by way of the studied mediators’ genes, which should be studied additional in future investigations.
Neonatal Proinflammatory Stress and Expression of Neuroinflammation-Associated Genes in the Rat Hippocampus
Differential impact of the neonatal proinflammatory stress (NPS) on the event of neuroinflammation in the hippocampus and induction of the depressive-like conduct in juvenile and grownup male and feminine rats was studied. NPS induction by bacterial lipopolysaccharide in the neonatal interval upregulated expression of the Il6 and Tnf mRNAs accompanied by the event of depressive-like conduct in the grownup male rats.
NPS elevated expression of the mRNAs for fractalkine and its receptor in the ventral hippocampus of the juvenile male rats, however didn’t have an effect on expression of mRNAs for the proinflammatory cytokines and soluble kind of fractalkine. NPS downregulated expression of fractalkine mRNA in the dorsal hippocampus of juvenile males.
Bluing Reagent |
|||
| BRT125 | ScyTek Laboratories | 125 ml | EUR 63 |
Bluing Reagent |
|||
| BRT3800 | ScyTek Laboratories | 1 Gal. | EUR 184 |
Bluing Reagent |
|||
| BRT500 | ScyTek Laboratories | 500 ml | EUR 76 |
Bluing Reagent |
|||
| BRT999 | ScyTek Laboratories | 1000 ml | EUR 88 |
Chymase reagent |
|||
| 30C-CP1129 | Fitzgerald | 5 units | EUR 2185 |
|
Description: Purified native Human Chymase reagent |
|||
Traut's Reagent |
|||
| 2330-1000 | Biovision | EUR 349 | |
Traut's Reagent |
|||
| 2330-500 | Biovision | EUR 207 | |
MTS Reagent |
|||
| 2808-1000 | Biovision | EUR 990 | |
MTS Reagent |
|||
| 2808-250 | Biovision | EUR 365 | |
MTT Reagent |
|||
| 2809-1G | Biovision | EUR 180 | |
MTT Reagent |
|||
| 2809-5G | Biovision | EUR 544 | |
Human Tyrosine-protein kinase ABL1 (ABL1) |
|||
| 1-CSB-RP043554h | Cusabio |
|
|
|
Description: Recombinant Human Tyrosine-protein kinase ABL1(ABL1) ,partial expressed in E.coli |
|||
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx119028 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx119048 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx133569 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx133815 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx000665 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| 20-abx007604 | Abbexa |
|
|
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| abx011613-100ul | Abbexa | 100 ul | EUR 411 |
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| abx033626-400ul | Abbexa | 400 ul | EUR 523 |
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| abx033626-80l | Abbexa | 80 µl | EUR 286 |
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| abx033627-400ul | Abbexa | 400 ul | EUR 523 |
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody |
|||
| abx033627-80l | Abbexa | 80 µl | EUR 286 |
Tyrosine-Protein Kinase ABL1 (Abl1) Antibody |
|||
| abx027683-400ul | Abbexa | 400 ul | EUR 523 |
Tyrosine-Protein Kinase ABL1 (Abl1) Antibody |
|||
| abx027683-80l | Abbexa | 80 µl | EUR 286 |
ABL1 Antibody |
|||
| 1-CSB-PA001140 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA001141 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA008496 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA008499 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA04355A0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IP; Recommended dilution: IHC:1:1000-1:2000, IP:1:200-1:2000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA959474 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/50-1/200.ELISA:1/10000 |
|||
ABL1 Antibody |
|||
| 1-CSB-PA547318 | Cusabio |
|
|
|
Description: A polyclonal antibody against ABL1. Recognizes ABL1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
ABL1 Antibody |
|||
| 35613-100ul | SAB | 100ul | EUR 252 |
ABL1 siRNA |
|||
| 20-abx906413 | Abbexa |
|
|
ABL1 siRNA |
|||
| 20-abx906414 | Abbexa |
|
|
ABL1 antibody |
|||
| 38124-100ul | SAB | 100ul | EUR 252 |
ABL1 Antibody |
|||
| ABD6083 | Lifescience Market | 100 ug | EUR 438 |
ABL1 Antibody |
|||
| DF6083 | Affbiotech | 200ul | EUR 304 |
|
Description: ABL1 Antibody detects endogenous levels of total ABL1. |
|||
ABL1 Antibody |
|||
| BF0419 | Affbiotech | 200ul | EUR 376 |
|
Description: ABL1 antibody detects endogenous levels of total ABL1. |
|||
ABL1 antibody |
|||
| 10R-1840 | Fitzgerald | 100 ul | EUR 403 |
|
Description: Mouse monoclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-30848 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-30850 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-31552 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-15334 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-51426 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal ABL1 antibody |
|||
ABL1 antibody |
|||
| 70R-51818 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal ABL1 antibody |
|||
Tyrosine-Protein Kinase ABL1 (ABL1) Antibody Pair |
|||
| abx117469-1pair5x96wellplates | Abbexa | 1 pair (5x96 well plates) | EUR 1010 |
BCA Reagent, 16ML |
|||
| C144-16ML | Arbor Assays | 16ML | EUR 163 |
Dissociation Reagent, 1ML |
|||
| X017-1ML | Arbor Assays | 1ML | EUR 109 |
Dissociation Reagent, 25ML |
|||
| X017-25ML | Arbor Assays | 25ML | EUR 258 |
Dissociation Reagent, 5ML |
|||
| X017-5ML | Arbor Assays | 5ML | EUR 122 |
Dissociation Reagent, 1ML |
|||
| X058-1ML | Arbor Assays | 1ML | EUR 73 |
Dissociation Reagent, 5ML |
|||
| X058-5ML | Arbor Assays | 5ML | EUR 109 |
Biolipidure-1002-Reagent |
|||
| Biolipidure-1002-10 | Cusabio | 10mL | EUR 196 |
|
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
HighGene transfection reagent |
|||
| RM09014 | Abclonal | 1000μl | EUR 270 |
LP4K Transfection Reagent |
|||
| LP4K | GenTarget | 1.0 ml / vial | EUR 304 |
|
Description: Lipid based transfection reagent for large plasmid and multiple plasmid transfection in both adhesive and suspenstion cell types. |
|||
n-Heptane Reagent |
|||
| HC5400 | Bio Basic | 1L | EUR 79 |
Tri-RNA Reagent |
|||
| FATRR-001 | Favorgen | 100ml | EUR 236 |
Tri-RNA Reagent |
|||
| FATRR-002 | Favorgen | 50ml | EUR 176 |
Tri-RNA Reagent |
|||
| FATRR-003 | Favorgen | 450ml | EUR 645 |
DTT (Cleland's reagent) |
|||
| DB0058 | Bio Basic | 5g | EUR 84.8 |
DTNB (Ellman's Reagent) |
|||
| DB0113 | Bio Basic | 5g | EUR 97.85 |
Ethyl acetate Reagent |
|||
| EC4600 | Bio Basic | 1L | EUR 79 |
TissueDigest Reagent, 20X |
|||
| T101 | Insitus Biotechnologies | 10ml | EUR 210 |
Convoy? Transfection Reagent |
|||
| 1110-1ml | ACTGene | EUR 341 | |
Griess Reagent Kit |
|||
| 30100 | Biotium | 1KIT | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1KIT |
|||
PhosphoBlocker Blocking Reagent |
|||
| AKR-103 | Cell Biolabs | 1L | EUR 328 |
|
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
|||
PhosphoBlocker Blocking Reagent |
|||
| AKR-104 | Cell Biolabs | 4L | EUR 711 |
|
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
|||
EL Transfection Reagent |
|||
| 20-abx098880 | Abbexa |
|
|
Mycoplasma Prevention Reagent |
|||
| 20-abx098886 | Abbexa |
|
|
Girard's reagent T |
|||
| 20-abx184099 | Abbexa |
|
|
FcR blocking Reagent |
|||
| 20-abx290024 | Abbexa |
|
|
Detection Reagent A |
|||
| abx296004-120ul | Abbexa | 120 ul | EUR 321 |
Mycoplasma Prevention Reagent |
|||
| 20-abx298005 | Abbexa |
|
|
Biolipidure-1002-Reagent |
|||
| Biolipidure-1002-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-103-Reagent |
|||
| Biolipidure-103-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-103-Reagent |
|||
| Biolipidure-103-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1201-Reagent |
|||
| Biolipidure-1201-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1201-Reagent |
|||
| Biolipidure-1201-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1301-Reagent |
|||
| Biolipidure-1301-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1301-Reagent |
|||
| Biolipidure-1301-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-203-Reagent |
|||
| Biolipidure-203-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-203-Reagent |
|||
| Biolipidure-203-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-206-Reagent |
|||
| Biolipidure-206-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-206-Reagent |
|||
| Biolipidure-206-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-405-Reagent |
|||
| Biolipidure-405-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-405-Reagent |
|||
| Biolipidure-405-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-502-Reagent |
|||
| Biolipidure-502-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-502-Reagent |
|||
| Biolipidure-502-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-702-Reagent |
|||
| Biolipidure-702-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-702-Reagent |
|||
| Biolipidure-702-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-802-Reagent |
|||
| Biolipidure-802-10 | Biolipidure | 10mL | EUR 196 |
|
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-802-Reagent |
|||
| Biolipidure-802-100 | Biolipidure | 100mL | EUR 1223 |
|
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Alcohol, Reagent (70%) |
|||
| EAS500 | ScyTek Laboratories | 500 ml | EUR 79 |
Alcohol, Reagent (70%) |
|||
| EAS999 | ScyTek Laboratories | 1000 ml | EUR 101 |
PureFection Transfection Reagent |
|||
| LV750A-1 | SBI | 1 ml | EUR 359 |
Biotin reagent (HRP) |
|||
| 65C-CE0202 | Fitzgerald | 5 mg | EUR 244 |
|
Description: HRP conjugated biotin labelling reagent |
|||
BSA (Reagent Grade) |
|||
| 30-AB79 | Fitzgerald | 1 kg | EUR 1552 |
|
Description: Reagent Grade Bovine Serum Albumin (99% pure) |
|||
BSA (Reagent Grade) |
|||
| 30-AB81 | Fitzgerald | 200 grams | EUR 476 |
|
Description: Reagent Grade Sulphydryl Blocked BSA (99% pure) |
|||
HAMA blocking reagent |
|||
| 85R-1001 | Fitzgerald | 1 gram | EUR 1974 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
|||
HAMA blocking reagent |
|||
| 85R-1001P | Fitzgerald | 1 gram | EUR 2190 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
|||
HAMA blocking reagent |
|||
| 85R-1003 | Fitzgerald | 1 gram | EUR 1974 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as Rapid Tests |
|||
HAMA blocking reagent |
|||
| 85R-1014 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in assays specific for clinical false positive samples |
|||
HAMA blocking reagent |
|||
| 85R-1025 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in immunoassays |
|||
HAMA blocking reagent |
|||
| 85R-1026 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in immunoassays |
|||
Specimen Preservation Reagent |
|||
| DA0970 | Daan Gene | 100 test/kit | Ask for price |
Bradford Dye Reagent |
|||
| 0209R | AthenaES | 100 ml | EUR 131 |
BODIPY-Acetylene Reagent |
|||
| 2594-1 | Biovision | EUR 207 | |
BODIPY-Acetylene Reagent |
|||
| 2594-5 | Biovision | EUR 675 | |
ExFect2000 Transfection Reagent |
|||
| T202-01 | Vazyme | 0.5 ml | EUR 227 |
ExFect2000 Transfection Reagent |
|||
| T202-02 | Vazyme | 1 ml | EUR 316 |
ExFect2000 Transfection Reagent |
|||
| T202-03 | Vazyme | 5 ml | EUR 1052 |
Lung Lysate |
|||
| 1402 | ProSci | 0.1 mg | EUR 191 |
|
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Brain Lysate |
|||
| 1403 | ProSci | 0.1 mg | EUR 191 |
|
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Liver Lysate |
|||
| 1404 | ProSci | 0.1 mg | EUR 191 |
|
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Kidney Lysate |
|||
| 1405 | ProSci | 0.1 mg | EUR 191 |
|
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Spleen Lysate |
|||
| 1406 | ProSci | 0.1 mg | EUR 191 |
|
Description: Spleen tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Thymus Lysate |
|||
| 1409 | ProSci | 0.1 mg | EUR 191 |
|
Description: Thymus tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Bladder Lysate |
|||
| 1410 | ProSci | 0.1 mg | EUR 191 |
|
Description: Bladder tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Colon Lysate |
|||
| 1411 | ProSci | 0.1 mg | EUR 191 |
|
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Cerebellum Lysate |
|||
| 1412 | ProSci | 0.1 mg | EUR 191 |
|
Description: Cerebellum tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
No important results of NPS had been discovered in the feminine rats. Therefore, the NPS induces long-term modifications in the expression of neuroinflammation-associated genes in completely different areas of the hippocampus, which finally results in the induction of neuroinflammation and growth of depressive-like conduct in male rats.
